Business

Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion

(TheNewswire) Calgary, AB – November 7, 2025 – TheNewswire - Voyageur...

articleVoyageur Pharmaceuticals LtdNovember 7, 20254/company/voyageur-pharmaceuticals-ltd/news/voyageur-pharmaceuticals-ltd-strengthens-board-of-directors-with-seasoned-financial-executive-virginia-alling-to-drive-us-market-expansion
Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion

About this update from Voyageur Pharmaceuticals Ltd

[{"type":"text","content":"Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, AB – November 7, 2025 –\n \n\n TheNewswire -\n \n\n Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC: VYYRF)\n \n\n (the “Company” or “Voyageur”), a Canadian developer\nof pharmaceutical-grade barium and iodine for medical imaging contrast\nmedia, is pleased to announce, subject to regulatory approval, the\nappointment of Virginia Alling as an independent director. This\naddition builds on the Company’s recent board enhancements with Wall\nStreet veterans Jeffrey J. Kraws and Christopher A. Van Buren, further\npositioning Voyageur for accelerated U.S. capital market access and\nstrategic growth.\n \n\n\n\n Ms. Alling brings over 30 years of experience in\ncorporate banking, capital markets, and strategic advisory for both\nprivately held and publicly traded companies. As Senior Vice President\n& Managing Director at PNC Bank in East Brunswick, NJ, she manages\na multi-billion-dollar portfolio of corporate clients in New Jersey\nand New York, including M&A, IPOs, ESOPs, leveraged finance, and\nrevenue optimization. Her expertise includes guiding private\nequity-backed and multigenerational family-owned businesses through\ncapital structure solutions, succession planning, and risk management.\nPreviously, Ms. Alling served as Vice President in Corporate Finance\n& Corporate Banking at JPMorgan Chase (formerly known as Chemical\nBank) in New Jersey and Assistant Vice President at Wells Fargo\n(formerly CoreStates) in Philadelphia. A Registered Investment Adviser\n(RIA) with FINRA Series 7 & 63 licenses, she holds an MBA from the\nRaymond A. Mason School of Business at the College of William &\nMary. Ms. Alling is also an active board member and nonprofit leader,\nwith a strong commitment to advancing technology, healthcare, and\nphilanthropy.\n \n\n\n\n “We are thrilled to welcome Virginia Alling to our\nboard,” said Brent Willis, Voyageur’s CEO. “Her excellent track\nrecord in executing U.S. public offerings, revenue optimization, and\ncross-border financing complements our recent appointments of Jeffrey\nK...

More updates from Voyageur Pharmaceuticals Ltd